Want Income for Life? This Dividend Stock Has Funded Investment Portfolios With Growing Passive Income for 57 Straight Years.

Altria has raised its dividend for 57 consecutive years and currently offers a 6% yield, supported by pricing power, cash flow and a payout ratio of about 80% of cash flow. Free cash flow per share rose 194.8% over the past decade, and the company holds roughly 150 million Anheuser-Busch InBev shares worth about $12.6 billion. The article sees the dividend as reasonably secure for now, but warns that declining cigarette volumes may eventually outpace price increases and says investors should monitor diversification, including On! nicotine pouches.

Analysis

The key risk is not simply declining cigarette volume; it is a change in the price/volume relationship. If additional price increases begin accelerating consumer exits, revenue resilience and the cash available for buybacks can weaken together. Buybacks can lift per-share cash flow while masking deterioration in the underlying customer base, so track total domestic cigarette volumes and organic operating cash flow alongside per-share measures. The asset cushion is also less durable than recurring earnings: selling the Anheuser-Busch InBev stake could support distributions temporarily, but would reduce future financial flexibility. Any sale could create a short-lived supply overhang in BUD shares, not a change in BUD’s operating outlook.

Over the next 1–3 months, the signal is in MO’s volume/price mix, smoke-free sales and management’s cash-flow and dividend commentary—not the dividend streak itself. Over 6–18 months, the pivotal question is whether smoke-free products can contribute enough cash to offset structural cigarette attrition; competing nicotine products and regulation could affect both adoption and economics. The contrarian point: the payout may be safer near term than the business model, but treating a high yield as evidence of long-duration dividend growth risks confusing asset support with recurring earnings power. No valuation or current operating data here establishes an attractive entry; a directional trade is not justified on this item alone.

Key Decisions for Investors

• Keep MO on a monitored-income list rather than adding solely on yield. Reassess after reported volume/price mix, organic cash flow, and smoke-free product results; verify whether per-share improvement is accompanied by stable total cash generation.
• Use a sustained acceleration in cigarette-volume declines, weakening price realization, or a reduced dividend-growth outlook as thesis-falsification triggers. Conversely, improving smoke-free contribution alongside resilient cash flow would reduce the structural-risk discount.
• Treat a potential MO sale of BUD shares as a possible temporary technical overhang for BUD, not a standalone short thesis. Watch for disclosed sale activity and distinguish it from changes in BUD fundamentals.
• No immediate pair or options trade: the article supplies neither current valuation nor enough operating detail to quantify downside versus dividend support.